(Q40134573)

17 September 2017

title

Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins (English)

1 reference

17 September 2017

Florence A Castelli

1

1 reference

17 September 2017

Mélanie Leleu

2

1 reference

17 September 2017

Sandra Pouvelle-Moratille

3

1 reference

17 September 2017

Sandrine Farci

4

1 reference

17 September 2017

Hassane M Zarour

5

1 reference

17 September 2017

Muriel Andrieu

6

1 reference

17 September 2017

Claude Auriault

7

1 reference

17 September 2017

André Ménez

8

1 reference

17 September 2017

Bertrand Georges

9

1 reference

17 September 2017

Bernard Maillere

10

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

European Journal of Immunology

17 September 2017

published in

1 reference

17 September 2017

volume

37

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

1513-1523

1 reference

Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

Rationally engineered therapeutic proteins with reduced immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Role of the specific T-cell response for clearance and control of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Epitopes of the NS3 protein of hepatitis C virus: recognition in HLA-DR4 transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

HLA-DR restricted peptide candidates for bee venom immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636783

7 January 2021

Identifiers

DOI

10.1002/EJI.200636783

1 reference

17 September 2017

1 reference